Asteria Health Issues Nationwide Recall of Testosterone Sterile Pellets Due to Metal Particulates
F.H. INVESTMENTS, Inc. (dba Asteria Health) is recalling over 194,000 testosterone sterile pellets due to the potential presence of metal particulate matter.
What Happened
F.H. INVESTMENTS, Inc., doing business as Asteria Health, has initiated a voluntary recall of its Testosterone 200 mg sterile pellets. The recall was prompted by the discovery of a foreign substance, specifically the potential presence of metal particulate matter within the product. The recall is currently classified as Class II by the FDA.
Which Products Are Affected
The recall affects 194,336 units distributed nationwide in the United States. The specific product details are as follows:
- Product Name: Testosterone, 200 mg, 1 Sterile Pellet
- Manufacturer: Asteria Health (432 Industrial Ln, Birmingham, AL 35211)
- NDC: 79559-1200-43
- Recall Number: D-0324-2026
- Affected Lot Numbers and Expiration Dates:
- Lot 251000127 (Exp. 06/03/2026)
- Lot 251000128 (Exp. 06/05/2026)
- Lots 251000133, 251000134, 251000135 (Exp. 06/16/2026)
- Lots 251000138, 251000139, 251000140, 251000141 (Exp. 06/25/2026)
- Lots 251000147, 251000148, 251000149 (Exp. 07/28/2026)
- Lots 251000156, 251000157 (Exp. 08/08/2026)
- Lots 251000164, 251000165, 251000166 (Exp. 08/22/2026)
- Lot 251000169 (Exp. 08/29/2026)
- Lots 251000171, 251000172 (Exp. 09/03/2026)
- Lot 251000180 (Exp. 09/19/2026)
What You Should Do
Healthcare providers and consumers should immediately stop using the affected lots listed above. The firm initiated the recall via notification letters sent to distributors and customers. For questions regarding the return of the product or to report adverse events, contact Asteria Health at their Birmingham, Alabama facility located at 432 Industrial Ln, Birmingham, AL 35211-4465.
Why This Matters
The presence of metal particulate matter in a sterile pellet intended for medical use poses a significant health risk, as foreign substances can lead to inflammation, infection, or other serious adverse reactions at the site of administration.
Source
Information provided by the FDA under Recall Event ID 98344.
Source: FDA Official Notice
Related Articles
Philips Recalls Azurion 7 M20 Systems Due to Unexpected Table Movement
FDA · February 24, 2026
Medline Industries Recalls 14 Fr Suction Catheter Kits Due to Incorrect Component Sizing
FDA · February 24, 2026
Philips Recalls Azurion 7 M12 Systems Due to Unexpected Table Movement Hazard
FDA · February 24, 2026